Loading...

    Explore
    • Policy Monitoring
    • Live Policy Feed
    • Billing Codes
    • Healthcare Providers
    • Health Insurance Payers
    • States
    • Service Lines
    • Taxonomy Codes
    Lookup tools
    • Billing Code Lookup
    • CPT Modifier Lookup
    • Provider Taxonomy Code Lookup
    • Healthcare Provider & Facility Lookup
    • Health Insurance Payer Lookup
    • Payer Contact Directory

    Policy & Benchmark Tools

    • Prior Authorization Lookup
    • Coverage Criteria Lookup
    • Timely Filing Lookup
    • Billing Code Reimbursement Rates
    • Payer Comparison Dashboard
    • Facility Comparison Dashboard
    • All tools

    Company

    • About OpenPayer
    • Data Sources
    • Request a Policy / Feedback
    • Trek Health
    OpenPayerby Trek Health
    LinkedInYouTube

    © 2026 Trek Health. All rights reserved.

    OpenPayer is built and maintained by Trek Health.

    v1.0.31
    OpenPayerPolicy UpdatesUrologyAetna Scrotal Ultrasonography Coverage Update | Op…
    Ask Trek AI about this page
    CurrentAetnaPolicy 0532

    Scrotal Ultrasonography

    Customize your policy alerts

    Sign up for Aetna Policy 0532 alerts

    Get alerted when Policy 0532 changes without checking for updates manually.

    Monitor payer policy activity

    Receive email alerts as soon as relevant payer policies are published or updated.

    This policy defines when scrotal ultrasonography is considered medically necessary or experimental for Aetna members, including indications such as scrotal masses, acute scrotal symptoms, infertility evaluation, trauma, and undescended testes.

    Policy Summary
    PayerAetna
    PolicyScrotal Ultrasonography
    Policy CodePolicy 0532
    Change TypeNo material change
    Effective DateAug 21, 2001
    Last ReviewJun 10, 2027
    Next Review DateJun 10, 2027
    Key ActionDocument the clinical indication and relevant exam findings when ordering scrotal ultrasonography to support medical necessity.
    SourceLink
    POLICY UPDATE CHANGES

    No material clinical or coverage changes in this revision.

    >=1Primary listed medically necessary indications
    1Covered CPT code (scrotum and contents)
    2ICD-10 codes listed as not covered
    Sens 0.73 / Spec 0.99Whirlpool sign (WS) performance
    >90%

    OpenPayer is powered by Trek Health's payer performance platform. Trek continuously ingests, validates, and normalizes Transparency in Coverage data alongside payer policies and other commercial payer data to create a structured payer intelligence foundation. OpenPayer uses this foundation to deliver personalized search results, dynamically generated policy pages, and tailored policy monitoring based on each user's payers, specialties, billing codes, and areas of interest. The same intelligence powers broader payer performance workflows, including reimbursement benchmarking, contract evaluation, payer negotiations, and financial decision-making.

    Torsion salvage rate if <6 hrs

    Coverage Criteria for Scrotal Ultrasonography

    inv-01: Medically necessary — Aetna considers scrotal ultrasonography medically necessary for any of the following:

    Aetna considers scrotal ultrasonography medically necessary for any of the following:

    Medically necessary indications: 1) Detection and characterization of scrotal mass lesions/tumors; OR 2) Detection of undescended (cryptorchid) testes in either of the following: to look for gonads or a uterus in a phenotypically male infant with bilateral non-palpable testes (evaluate for disorder of sexual development); OR in obese boys in whom intra-canalicular testes may be difficult to palpate and would change the surgical approach (from laparoscopic to inguinal); OR 3) Diagnosis of suspected testicular torsion; OR 4) Evaluation of hydroceles; OR 5) Evaluation of infertile men; OR 6) Evaluation of scrotal pain and/or swelling (acute scrotal symptoms); OR 7) Evaluation of scrotal injury/trauma; OR 8) Evaluation of varicoceles.

    Preserves policy OR logic as listed.

    inv-02: Experimental, investigational, or unproven — Scrotal ultrasonography is considered experimental, investigational, or unproven for all other indications, including (but not limited to):

    Scrotal ultrasonography is considered experimental, investigational, or unproven for all other indications, including (but not limited to):

    Experimental/Unproven indications: 1) Initial evaluation for infertility unless physical examination of the scrotum is difficult or inadequate, or when a testicular mass is suspected; OR 2) Surveillance of testicular microlithiasis in the absence of additional risk factors (e.g., history of cryptorchidism, testicular atrophy <12 ml, prior testicular cancer).

    Policy lists these examples as unproven uses.

    inv-03: Scrotal/Transrectal Ultrasound Indications (Initial infertility evaluation and scrotal pathology)

    Covered when clinical indications or examination findings warrant imaging:

    Indications: - Scrotal ultrasound when physical examination is difficult or inadequate (e.g., obesity, contracted dartos muscle) or when a testicular mass is suspected. - Transrectal ultrasound (TRUS) for patients who are azoospermic or have low ejaculate volume with features suggesting ejaculatory duct obstruction (e.g., acidic specimen, semen volume <1.5 ml, with normal serum testosterone, palpable vas deferens). - Scrotal/testicular ultrasound for suspected obstructive azoospermia when testicular volumes and hormones are normal and azoospermia is present. - Use color Doppler ultrasound when the examination is limited to evaluate spermatic cord veins or when torsion is suspected. - Routine use of ultrasound to detect subclinical (non-palpable) varicocele is discouraged; palpation is sufficient for clinically significant varicoceles.

    Reflects AUA/ASRM, French guidelines and UpToDate summaries.

    inv-04: Testicular torsion imaging guidance — Ultrasound findings relevant to torsion:

    Ultrasound findings relevant to torsion:

    Whirlpool sign utility: The whirlpool sign (WS) is defined as a spiral-like pattern of the spermatic cord on ultrasound. Pooled estimates show sensitivity ~0.73 and specificity ~0.99 for testicular torsion; removal of neonates increases pooled sensitivity to ~0.92 while specificity remains ~0.99. When correctly diagnosed the WS may be viewed as a very definitive sign for torsion, though its role is limited in neonates.sensitivity 0.73, specificity 0.99

    Meta-analysis (McDowall et al.) results.

    inv-05: Testicular microlithiasis follow-up — Coverage/management stance for TML:

    Coverage/management stance for TML:

    TML management: Isolated testicular microlithiasis (TML) without other risk factors: routine follow-up imaging or surveillance is not advised. If additional risk factors are present, annual ultrasound is advised up to age 55. If TML is identified in association with a testicular mass, urgent referral to a specialist center is recommended.age <=55 for annual US if risk factors present

    ESUR scrotal imaging subcommittee guidance.

    Aetna excludes routine ultrasound surveillance for testicular microlithiasis (TML) when no additional risk factors are present. The policy specifies that surveillance is not advised for isolated TML in the absence of risk factors such as a history of cryptorchidism, prior testicular cancer, or testicular atrophy (testis volume <12 mL).

    If additional risk factors are present, the policy references consideration of periodic imaging (for example, annual ultrasound up to age 55 per guideline guidance), and an urgent specialist referral is recommended when TML is identified in conjunction with a testicular mass.

    Aetna discourages routine scrotal ultrasound as part of the initial infertility evaluation. Scrotal ultrasonography is not routinely indicated for all men presenting for initial fertility assessment and should be ordered only when the clinical examination cannot be adequately performed (for example, obese patients or contracted dartos muscle) or when a testicular mass is suspected.

    Claims submitted for CPT 76870 associated with encounter codes for initial fertility testing (e.g., Z31.41, Z31.49) may be subject to denial if the selection criteria in the policy are not met; ensure documentation supports a covered indication before ordering and billing.

    This Clinical Policy Bulletin provides Aetna’s guidance to assist in administering plan benefits and is not a contract or an offer of coverage. It contains a general description of plan or program benefits, may be updated, and does not replace the provider’s clinical judgment or plan-specific benefit documents. Providers remain solely responsible for medical advice and treatment of members.

    Scrotal ultrasonography for the initial evaluation of infertility is not medically necessary unless one of the following applies: the physical examination of the scrotum is difficult or inadequate (for example, obesity or contracted dartos muscle) or a testicular mass is suspected. When these criteria are not met, the policy lists initial infertility encounter codes (e.g., Z31.41, Z31.49) as not covered.

    When ordering ultrasound for infertility indications that meet the policy, document the specific exam limitations or mass suspicion and relevant semen analysis or physical findings to support medical necessity.

    Ultrasound evaluation for undescended testis (UDT) has limited diagnostic value and is frequently overused. The policy cites studies showing modest accuracy and potential delays in definitive surgical management when ultrasound is performed routinely.

    Routine preoperative ultrasound for UDT is generally discouraged and may be considered unnecessary when ordering without clear, guideline-supported indications; providers should rely primarily on clinical examination and surgical findings when planning management unless specific circumstances (e.g., non-palpable testes, obesity) justify imaging.

    Coding and Codes

    Covered CPT CodesCPTCovered
    76870Ultrasound, scrotum and contents.
    Covered ICD-10 Codes (when selection criteria met)ICD-10Covered
    C63.2Malignant neoplasm of scrotum.
    D29.4Benign neoplasm of scrotum.
    D40.10Neoplasm of uncertain behavior of testis.
    D40.11Neoplasm of uncertain behavior of testis.
    D40.12Neoplasm of uncertain behavior of testis.
    I86.1Scrotal varices.
    N43.0Hydrocele and spermatocele.
    N43.1Hydrocele and spermatocele.
    N43.2Hydrocele and spermatocele.
    N43.3Hydrocele and spermatocele.
    1–10 of 46
    1/5
    ICD-10 Codes Not Covered in Certain CircumstancesICD-10Not Covered
    Z31.41Encounter for fertility testing [Initial evaluation for infertility unless physical examination of the scrotum is difficult or inadequate, or when a testicular mass is suspected].
    Z31.49Encounter for other procreative investigation and testing [Initial evaluation for infertility unless physical examination of the scrotum is difficult or inadequate, or when a testicular mass is suspected].
    No explicit code list in this excerptmixed
    No codes listed
    Varicocele diagnostic criterion — intra-scrotal veins larger than 2 mm
    Varicocele diagnostic thresholdIntra-scrotal veins larger than 2 mm
    Clinical useColor Doppler US allows more objective and precise assessment of varicoceles
    Modality noteDiagnosis is made by demonstrating dilated intratesticular veins (>2 mm) on scrotal ultrasound

    Provider Actions, Documentation, and Billing Notes

    Prior Authorization

    Use CPT 76870 only when selection criteria are met

    CPT 76870 (Ultrasound, scrotum and contents) is a covered procedure when the policy’s selection criteria are met; providers should verify that the clinical indication maps to a covered ICD‑10 code prior to billing.

    • Covered CPT code: 76870 — Ultrasound, scrotum and contents.
    • Ensure the documented clinical indication corresponds to one of the policy’s medically necessary indications before submission.
    Prior Authorization

    Order scrotal US only for indicated infertility scenarios

    Do not order scrotal ultrasound routinely for the initial infertility evaluation. Reserve imaging when the scrotal physical examination is difficult or inadequate (e.g., obesity, contracted dartos) or when a testicular mass is suspected; TRUS is indicated only for patients with semen analysis findings suggestive of ejaculatory duct obstruction.

    • Scrotal US is discouraged as part of routine initial infertility workup.
    • Use color Doppler US when the exam is limited (obesity, contracted dartos) or when a mass is suspected.

    Background and Rationale

    Scrotal ultrasonography is a sensitive modality for identifying intra-scrotal abnormalities and distinguishing testicular from para-testicular lesions. Color Doppler ultrasound is particularly valuable for assessing scrotal blood flow in acute scrotal conditions, such as suspected testicular torsion, and for evaluating testicular perfusion after trauma.

    Ultrasound is also useful for evaluation of hydroceles, varicoceles (defined in the policy as intra-scrotal veins larger than 2 mm), undescended testes in selected circumstances, and as part of infertility workup when the physical examination is inadequate or a mass is suspected.

    Definitions

    Color Doppler ultrasound
    DefinitionColor Doppler ultrasound: imaging modality that reveals scrotal blood flow, used especially for acute scrotal assessment and suspected torsion.
    Primary indicationAssessment of acute scrotal symptoms (pain or swelling), especially suspected testicular torsion
    Additional usesMore accurate and reliable than physical exam with gray-scale US for differential diagnosis of acute scrotum; useful to assess testicular perfusion after trauma
    Hydrocele preventing adequate palpation
    DefinitionHydrocele preventing adequate palpation: a hydrocele large enough that testes cannot be adequately palpated, indicating need for scrotal ultrasound.
    Clinical implicationPatients with such hydroceles should undergo scrotal ultrasound to evaluate testes and identify intrahydrocele calculi
    Policy Summary
    PayerAetna
    PolicyScrotal Ultrasonography
    Policy CodePolicy 0532
    Change TypeNo material change
    Effective DateAug 21, 2001
    Last ReviewJun 10, 2027
    Next Review DateJun 10, 2027
    Key ActionDocument the clinical indication and relevant exam findings when ordering scrotal ultrasonography to support medical necessity.
    SourceLink
    On This Page
    Coverage Criteria for Scrotal UltrasonographyCoding and CodesProvider Actions, Documentation, and Billing NotesBackground and RationaleDefinitions
  1. TRUS should be reserved for men with semen analysis findings consistent with ejaculatory duct obstruction.
  2. Prior Authorization

    No special prior‑authorization process specified

    The policy does not specify a separate prior authorization program or unique prior authorization steps for scrotal ultrasonography; follow standard plan administrative procedures and verify coverage using the selection criteria in this policy.

    • No explicit prior‑authorization workflow for scrotal ultrasound is detailed in this Clinical Policy Bulletin.
    • Confirm coverage by ensuring the exam meets the medically necessary indications listed in the policy.
    Note

    Provider action

    (No content specified in source or brief for this placeholder.)

    Step Therapy

    No step therapy required

    No step therapy requirements are specified for scrotal or transrectal ultrasonography in this policy.

    • The policy lists no prerequisites, staged treatments, or step edits prior to ordering ultrasound.
    Note

    Provider action

    (No content specified in source or brief for this placeholder.)

    Documentation Required

    Document the clinical indication that supports medical necessity

    Document the specific clinical indication and that it matches one of the policy’s medically necessary reasons (e.g., scrotal mass, suspected torsion, hydrocele, infertility when the scrotal exam is difficult/inadequate, trauma, varicocele, undescended testis).

    • Record the clinical scenario that justifies imaging and reference the corresponding medically necessary criterion from the policy.
    • Ensure the indication maps to a covered ICD‑10 code when submitting the claim.
    Documentation Required

    Include exam findings and semen analysis to support the indication

    Include relevant physical exam findings and diagnostic test results to support medical necessity when ordering or billing for scrotal or transrectal ultrasound (e.g., difficult/inadequate scrotal exam due to obesity or contracted dartos, non‑palpable or suspicious mass, semen analysis results suggesting obstructive azoospermia).

    • Document specific exam limitations (obesity, contracted dartos) or palpation findings (non‑palpable testis, palpable mass).
    • For infertility/TRUS indications, include semen analysis details (azoospermia, low semen volume <1.5 mL, acidic semen) if applicable.
    Note

    Provider responsibilities and policy status

    Providers are independent contractors and are solely responsible for medical advice and treatment; this Clinical Policy Bulletin is a partial description of plan benefits, may be updated, and does not constitute a contract or medical advice.

    • This bulletin assists in administering plan benefits but is not an offer of coverage.
    • Treating providers retain responsibility for clinical decisions and member care.
    Denial Risk

    Denial risk when using infertility encounter codes without supporting exam findings

    Claims filed with ICD‑10 codes Z31.41 or Z31.49 (encounters for fertility testing/procreative investigation) are listed as not covered when used for routine initial infertility evaluation unless the scrotal exam is difficult/inadequate or a testicular mass is suspected; such submissions risk denial if selection criteria are not met.

    • Z31.41 and Z31.49 are specifically noted as not covered for initial infertility evaluation when selection criteria are not satisfied.
    • Ensure documentation demonstrates exam inadequacy or a suspected mass to avoid denial.
    Denial Risk

    Avoid routine scrotal US for initial infertility evaluation

    Routine ordering of scrotal ultrasound for the initial infertility evaluation is discouraged and may be considered inappropriate use; order imaging only when the physical exam is difficult/inadequate or a testicular mass is suspected to avoid unnecessary utilization.

    • Routine screening in initial infertility without exam limitations or mass suspicion is discouraged.
    • Ordering without appropriate indication may lead to challenge or denial.
    Denial Risk

    Risk of inappropriate ultrasound use for undescended testis (UDT)

    Ultrasound is of limited value for undescended testis (UDT) and has been widely overused; ordering preoperative or routine US for UDT without a clear indication may delay care, increase costs, and be challenged.

    • Studies show ultrasound correctly predicted surgical findings in only ~54% of patients and was associated with delays in definitive management.
    • Avoid routine preoperative ultrasound for UDT unless specifically justified.
    Note

    Policy bulletin is guidance, not a contract

    Clinical Policy Bulletins are developed to assist in administering plan benefits and do not constitute a contract or medical advice; they may be updated and participating providers remain responsible for member care.

    • The bulletin is a general description of plan benefits and is subject to change.
    • Providers are independent contractors and responsible for treatment decisions.
    UtilitySonographic identification of calculi in the hydrocele may prevent further imaging and unnecessary surgery
    Whirlpool sign (WS)
    DescriptionWhirlpool sign (WS): spiral-like pattern of the spermatic cord on ultrasound indicative of testicular torsion.
    Diagnostic performancePooled sensitivity ~0.73 and specificity ~0.99; sensitivity increases (to ~0.92) when neonates are excluded
    Clinical noteWhen correctly diagnosed, WS may be viewed as a very definitive sign for torsion in pediatric and adult populations; limited role in neonates
    Testicular microlithiasis (TML)
    DefinitionTesticular microlithiasis (TML): ultrasound finding of intratesticular microcalcifications.
    Follow-up guidanceIsolated TML without risk factors: follow-up imaging or routine surveillance is not advised
    Risk-based surveillanceIf other risk factors are present, annual ultrasound up to age 55 is advised; if TML is found with a testicular mass, urgent specialist referral is advised
    Clinical Policy Bulletin
    Nature of documentClinical Policy Bulletin: Aetna-developed guidance to assist in administering plan benefits; not an offer of coverage or medical advice.
    Contractual noteThis bulletin contains only a partial, general description of plan or program benefits and does not constitute a contract; specifics found in plan documents
    Provider responsibilityParticipating providers are independent contractors and are solely responsible for medical advice and treatment of members